These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 30537000)
1. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
2. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis. Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124 [TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis. Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10. Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116 [TBL] [Abstract][Full Text] [Related]
7. β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells. Huang Z; Li G; Zhang Z; Gu R; Wang W; Lai X; Cui ZK; Zeng F; Xu S; Deng F BMC Cancer; 2019 Nov; 19(1):1142. PubMed ID: 31771535 [TBL] [Abstract][Full Text] [Related]
8. Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs). Sameermahmood Z; Balasubramanyam M; Saravanan T; Rema M Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3305-11. PubMed ID: 18660423 [TBL] [Abstract][Full Text] [Related]
9. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098 [TBL] [Abstract][Full Text] [Related]
10. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis. Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072 [TBL] [Abstract][Full Text] [Related]
12. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. Liu Y; Ren CC; Yang L; Xu YM; Chen YN J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987 [TBL] [Abstract][Full Text] [Related]
13. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638 [TBL] [Abstract][Full Text] [Related]
14. LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells. Liu WT; Jing YY; Yan F; Han ZP; Lai FB; Zeng JX; Yu GF; Fan QM; Li R; Zhao QD; Wu MC; Wei LX Cell Adh Migr; 2017 Jan; 11(1):13-23. PubMed ID: 26745593 [TBL] [Abstract][Full Text] [Related]
15. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. Yoshida D; Koketshu K; Nomura R; Teramoto A J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720 [TBL] [Abstract][Full Text] [Related]
16. The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells. Kayali AG; Lopez AD; Hao E; Hinton A; Hayek A; King CC PLoS One; 2012; 7(6):e38721. PubMed ID: 22761699 [TBL] [Abstract][Full Text] [Related]
17. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway. Xia R; Xu G; Huang Y; Sheng X; Xu X; Lu H Life Sci; 2018 May; 201():111-120. PubMed ID: 29604270 [TBL] [Abstract][Full Text] [Related]
18. CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma. Lv B; Yang X; Lv S; Wang L; Fan K; Shi R; Wang F; Song H; Ma X; Tan X; Xu K; Xie J; Wang G; Feng M; Zhang L Mol Neurobiol; 2015 Dec; 52(3):1263-1268. PubMed ID: 25326893 [TBL] [Abstract][Full Text] [Related]
19. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]